Neurohormonal Activation and Progression of Heart Failure
- 1 January 1998
- journal article
- current insights-and-new-treatment-options
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 32 (Supplement) , S16-S21
- https://doi.org/10.1097/00005344-199806321-00004
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Meta-analysis of the use of low-dose beta-adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathyThe American Journal of Cardiology, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations.Heart, 1995
- Cardiac failure: A revised paradigmJournal of Cardiac Failure, 1995
- Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failureJournal of Molecular and Cellular Cardiology, 1995
- Left ventricular hypertrophy: An initial response to myocardial injuryThe American Journal of Cardiology, 1992
- Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and managementThe American Journal of Cardiology, 1991
- Plasma endothelin-1 levels in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1991
- Cardiomyopathy of OverloadNew England Journal of Medicine, 1990
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983